Research suggests that pomegranate juice may offer meaningful benefits for blood pressure regulation and broader cardiovascular health, with proposed mechanisms including reductions in oxidative stress, improved endothelial function, inhibition of platelet aggregation, and slowed lipid accumulation in arterial walls. The available evidence draws on a 2018 review that synthesized findings from both laboratory studies and clinical trials, with the clinical data specifically associating regular pomegranate juice consumption with reduced blood pressure and slowed atherosclerosis progression in human participants. The bioactive compounds credited with these effects include ellagitannins, ellagic acid, anthocyanins, and various flavonoids. It is worth noting that the current evidence base is limited to a single review rather than a body of independent randomized controlled trials or meta-analyses, so while the direction of findings is encouraging, firmer conclusions will require a broader and more rigorous body of research.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Vasculoprotective Effects of Pomegranate (Punica granatum L.). | Review | 2018 | Supports | 100 |